[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR14.30]
[Page 144]
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN
SERVICES
PART 14 PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE--Table of Contents
Subpart B Meeting Procedures
Sec. 14.30 Chairman of an advisory committee.
(a) The advisory committee chairman has the authority to conduct
hearings and meetings, including the authority to adjourn a hearing or
meeting if the chairman determines that adjournment is in the public
interest, to discontinue discussion of a matter, to conclude the open
portion of a meeting, or to take any other action to further a fair and
expeditious hearing or meeting.
(b) If the chairman is not a full-time employee of FDA, the
executive secretary or other designated agency employee, or alternate,
is to be the designated Federal employee who is assigned to the advisory
committee. The designated Federal employee is also authorized to adjourn
a hearing or meeting if the employee determines adjournment to be in the
public interest.
Back to Top
© 2007 Betterchem Corp.
|
